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Pseudomonas aeruginosa and Staphylococcus aureus are opportunistic pathogens and commonly found in polymicrobial biofilm-associated diseases, namely chronic wounds. Their co-
existence in a biofilm contributes to an increased tolerance to antibiotics. Combined treatments of bacteriophages and antibiotics have shown a promising antibiofilm activity, since their
mechanisms of bacteria-killing differ profoundly. In this study, 48 hours old mono and dual-species biofilms were treated with a newly isolated P. aeruginosa phage (vB_PaM_EPA1) and
gentamicin (GEN) alone and in simultaneous or sequential combinations. After 24 hours treatment, the number of viable cells were enumerated by CFU counting and observed under
confocal laser scanning microscopy (CLSM) with fluorescence probes. Probes were designed to specifically target the bacterial species and consists of a recombinant tail fiber protein (P.
aeruginosa-specific) fused to mCherry (EPA1_TFP+mCherry) and a cell wall binding domain of a phage endolysin (S. aureus specific) fused to GFP (LM12_AMI-SH3+GFP).
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Overall, from this study, two main conclusions emerge. First, the combined treatment with a sequential application of phages and then antibiotic is the most promising approach to combat infectious biofilms when
compared with their individual and simultaneous treatments. Second, the majority of the studies of antibiofilm approaches are conducted in mono-species biofilms, and as demonstrated herein, the treatment
outcomes are completely different when a second species is added. So, to achieve success, phages should be tested prior to antibiotic addition.
We aimed at assessing the antibiofilm activity
of combinations of gentamicin and a P.
aeruginosa specific phage vB_PaM_EPA1 in
order to infer if combination of antimicrobials
can potentiate biofilm killing in a synergistic
effect.
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Figure 1. Phage EPA1 analysis. (A) TEM image. Scale bar = 50
nm. (B) One step growth curve.
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Figure 2. Treatment of P. aeruginosa PAO1 48 hours biofilms with gentamicin at different concentrations. A prefix PHAGE
indicates EPA1 in MOI 1, 1/2 MIC indicates the dose of antibiotics with 1/2x MIC value, MIC indicates the dose of antibiotics with
1x MIC value of P. aeruginosa, 2 MIC indicates the dose of antibiotics with 2x MIC value of P. aeruginosa, 8 MIC indicates the
dose of antibiotics with 8x MIC value of P. aeruginosa, PHAGE + antibiotic indicates simultaneous treatment and PHAGE 6 H +
antibiotics indicates phage was added first then antibiotic was added with 6 hours delay. * Under detection limit (<102). (^)
Statistical differences between the control and treated biofilms were determined by two-way repeated-measures analysis of
variance (ANOVA) with a Tukey’s multiple comparison test.
Figure 3. 3D reconstructions of confocal stacks of images of mono-species P. aeruginosa biofilms. (a) Control, (b) 6 hours phage
treatment, (c) 24 hours phage treatment, (d) 24 hours Gentamicin treatment, (e) 24 hours simultaneous treatment, (f) 24 hours
sequential treatment. All biofilms were stained with EPA1_TFP (with mCherry) recombinant protein. Scale bar represents 50 µm.
Figure 4. Treatment of 48 hours dual-species biofilms. (a) P. aeruginosa number of viable cells. (b) S. aureus number of viable
cells. A prefix PHAGE indicates EPA1 in MOI 1, 6 H and 24 H indicates treatment time period for 6 and 24 hours, MIC indicates
the dose of antibiotics with 1x MIC value of P. aeruginosa, 8 MIC indicates the dose of antibiotics with 8xMIC value of P.
aeruginosa, PHAGE + antibiotic indicates simultaneous treatment and PHAGE 6 H + antibiotics indicates phage was added first
then antibiotic was added with 6 hours delay. * Under detection limit (<102). (^) Statistical differences between the control and
treated biofilms. (#) Statistical differences between the simultaneously and sequentially treated biofilms. Statistical differences
were determined by two-way repeated-measures analysis of variance (ANOVA) with a Tukey’s multiple comparison test.
Figure 5. 3D reconstructions of confocal stacks of images of dual-species of P. aeruginosa and S. aureus biofilms. (a) Control, (b) 6
hours phage treatment, (c) 24 hours phage treatment, (d) 24 hours Gentamicin with MIC treatment, (e) 24 hours simultaneous
treatment, (f) 24 hours sequential treatment. 48 hours old intact biofilms were stained by using LM12_AMI-SH3 (with GFP) and
EPA1_TFP (with mCherry) recombinant proteins. Scale bar represents 50 µm.
Table 2. General overview of the efficacy of combined
treatments in 48 hours P. aeruginosa mono-species
biofilms. Synergistic – the biofilm reduction using phage-
antibiotic combinations is greater than the sum of their
individual treatments. Additive – the biofilm reduction
using phage-antibiotic combination is similar to the sum
of their individual treatments.
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EPA1 or GEN alone had a modest effect in reducing biofilm bacteria. However, when applied
simultaneously, a profound improvement in the killing effect was observed. Moreover, an
impressive biofilm eradication was observed when gentamicin was added sequentially after 6
hours of phage treatment.
Dual-species biofilms were more tolerant to all treatments than mono-species P. aeruginosa
biofilms. Nevertheless, the sequential treatment at 8xMIC almost eradicated P. aeruginosa
biofilm cells, but it did not increase the antimicrobial effect on S. aureus. CLSM images indicate
that both species were randomly distributed throughout the biofilm 3D structures.
EPA1 possesses a broad lytic spectrum on strain tested.
Furthermore, the phage had a high EOP in 14 out of 20 P.
aeruginosa strains.
EPA1 has an icosahedral head with 69 nm in diameter and a
contractile tail of 145 x 24 nm. According to Ackermann’s
classification, EPA1 belongs to the Caudovirales order and
Myoviridae family.
The latent period of EPA1 was around 10 minutes, and the
burst size was approximately 34 progeny phages per infected
cell.
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